Supportive care for the cancer patient

Withrow & MacEwen's Small Animal Clinical Oncology

Volumn , Issue , 2007, Pages 291-346

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882833171     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072160558-6.50019-8     Document Type: Chapter

References (327)

1. Yoxall AT Pain in small animals: its recognition and control. J Small Anim Pract 1978, 19:423-438.
2. Fan TM, de Lorimier LP, Charney SC, et al. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. J Vet Intern Med 2005, 19:74-80.
3. Ramirez O, Dodge RK, Page RL, et al. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 1999, 40:517-522.
4. Bateman KE, Catton PA, Pennock PW, et al. 0-7-21 radiation therapy for the palliation of advanced cancer in dogs. J Vet Intern Med 1994, 8:394-399.
5. Karai L, Brown DC, Mannes AJ, et al. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 2004, 113:1344-1352.
6. Flecknell PA, Waterman-Pearson AE Pain management in animals 2000, WB Saunders, London.
7. Gaynor JS, Muir WW Handbook of veterinary pain management 2002, Mosby, St Louis.
8. Bronson RT Variation in age at death of dogs of different sexes and breeds. Am J Vet Res 1982, 43:2057-2059.
9. Foundation MA Animal health survey 1998, Companion Animal News, Engelwood, Colorado.
10. Bonica JJ Treatment of cancer pain: current status and future needs. Advances in pain research and therapy 1985, Raven Press, New York. H.L. Fields (Ed.).
11. Portenoy RK, Lesage P Management of cancer pain. Lancet 1999, 353:1695-1700.
12. Lascelles BDX, Capner CA, Waterman-Pearson AE A survey of current British veterinary attitudes to peri-operative analgesia for cats and small mammals. Vet Rec 1999, 145:601-604.
13. Joubert KE The use of analgesic drugs by South African veterinarians. . J S Afr Vet Assoc 2001, 72:57-60.
14. Watson AD, Nicholson A, Church DB, et al. Use of anti-inflammatory and analgesic drugs in dogs and cats. Aust Vet J 1996, 74:203-210.
15. Dohoo SE, Dohoo IR Attitudes and concerns of Canadian animal health technologists toward postoperative pain management in dogs and cats. Can Vet J 1998, 39:491-496.
16. Dohoo SE, Dohoo IR Factors influencing the postoperative use of analgesics in dogs and cats by Canadian veterinarians. Can Vet J 1996, 37:552-556.
17. Dohoo SE, Dohoo IR Postoperative use of analgesics in dogs and cats by Canadian veterinarians. Can Vet J 1996, 37:546-551.
18. Williams VM, Lascelles BD, Robson MC Current attitudes to, and use of, peri-operative analgesia in dogs and cats by veterinarians in New Zealand. N Z Vet J 2005, 53:193-202.
19. Hamill RJ The physiologic and metabolic response to pain and stress. Handbook of critical care pain management 1994, McGraw-Hill, New York. R.J. Hamill, J.C. Rowlingson (Eds.).
20. Lascelles BD, Main DC Surgical trauma and chronically painful conditions-within our comfort level but beyond theirs?. J Am Vet Med Assoc 2002, 221:215-222.
21. Brambell FWR Report of technical committee to enquire into the welfare of animals kept under intensive husbandry systems (Cmnd 2836) 1965, HM Stationery Office, London.
22. Page GG, Blakely WP, Ben-Eliyahu S Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001, 90:191-199.
23. Sandoval BA, Robinson AV, Sulaiman TT, et al. Open versus laparoscopic surgery: a comparison of natural antitumoral cellular immunity in a small animal model. Am Surg 1996, 62:625-630. (discussion, 630-621).
24. Kutza J, Gratz I, Afshar M, et al. The effects of general anaesthesia and surgery on basal and interferon stimulated natural killer cell activity of humans. Anaesth Analg 1997, 85:918-923.
25. Page GG, Ben-Eliyahu S, Liebeskind JC The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav Immun 1994, 8:241-250.
26. Conzemius MG, Hill CM, Sammarco JL, et al. Correlation between subjective and objective measures used to determine severity of postoperative pain in dogs. J Am Vet Med Assoc 1997, 210:1619-1622.
27. Gingerich DA, Strobel JD Use of client-specific outcome measures to assess treatment effects in geriatric, arthritic dogs: controlled clinical evaluation of a nutraceutical. Vet Ther 2003, 4:56-66.
28. Hielm-Bjorkman AK, Kuusela E, Liman A, et al. Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J Am Vet Med Assoc 2003, 222:1552-1558.
29. Wiseman ML, Nolan AM, Reid J, et al. Preliminary study on owner-reported behaviour changes associated with chronic pain in dogs. Vet Rec 2001, 149:423-424.
30. Wiseman-Orr ML, Nolan AM, Reid J, et al. Development of a questionnaire to measure the effects of chronic pain on health-related quality of life in dogs. Am J Vet Res 2004, 65:1077-1084.
31. Committee WHOE Cancer pain relief 1996, World Health Organization, Geneva, . ed 2.
32. Lascelles BD Relief of chronic cancer pain. BSAVA manual of small animal oncology 2003, British Small Animal Veterinary Association, Cheltenham, United Kingdom. J.M. Dobson, B.D. Lascelles (Eds.).
33. Khan KN, Venturini CM, Bunch RT, et al. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol 1998, 26:612-620.
34. Wilson JE, Chandrasekharan NV, Westover KD, et al. Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Am J Vet Res 2004, 65:810-818.
35. Ostrom RS, Gregorian C, Drenan RM, et al. Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP. Am J Physiol Cell Physiol 2001, 281:C524-C531.
36. Rossat J, Maillard M, Nussberger J, et al. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther 1999, 66:76-84.
37. Zweifel BS, Davis TW, Ornberg RL, et al. Direct evidence for a role of cyclooxygen ygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Cancer Res 2002, 62:6706-6711.
38. Raegg C, Dormond O Suppression of tumor angiogenesis by nonsteroidal anti-inflammatory drugs: a new function for old drugs. Scientific World J 2001, 1:808-811.
39. Koki A, Khan NK, Woerner BM, et al. Cyclooxygenase-2 in human pathological disease. Adv Exp Med Biol 2002, 507:177-184.
40. Kulkarni S, Rader JS, Zhang F, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 2001, 7:429-434.
41. Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000, 89:2637-2645.
42. Buckman SY, Gresham A, Hale P, et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19:723-729.
43. Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999, 59:991-994.
44. Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999, 59:987-990.
45. Yoshimura R, Sano H, Masuda C, et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 2000, 89:589-596.
46. Howe LR, Subbaramaiah K, Patel J, et al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res 2002, 62:5405-5407.
47. Koki AT, Masferrer JL Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 2002, 9:28-35.
48. Burke CA, Bauer WM, Lashner B Chemoprevention of colorectal cancer: slow, steady progress. Cleve Clin J Med 2003, 70:346-350.
49. Ricchi P, Zarrilli R, Di Palma A, et al. Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br J Cancer 2003, 88:803-807.
50. Friis S, Sorensen HT, McLaughlin JK, et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003, 88:684-688.
51. Kishi K, Petersen S, Petersen C, et al. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 2000, 60:1326-1331.
52. Khan KN, Stanfield KM, Trajkovic D, et al. Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet Pathol 2001, 38:116-119.
53. Dore M, Lanthier I, Sirois J Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 2003, 40:207-212.
54. McEntee MF, Cates JM, Neilsen N Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 2002, 39:428-436.
55. Pestili de Almeida EM, Piche C, Sirois J, et al. Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J Histochem Cytochem 2001, 49:867-875.
56. Knottenbelt CM, Simpson JW, Tasker S, et al. Preliminary clinical observations on the use of piroxicam in the management of rectal tubulopapillary polyps. J Small Anim Pract 2000, 41:393-397.
57. Knapp DW, Richardson RC, Bottoms GD, et al. Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors. Cancer Chemother Pharmacol 1992, 29:214-218.
58. Knapp D, Richardson R, Tck C, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994, 8:273-278.
59. Knapp DW, Chan TC, Kuczek T, et al. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells. Am J Vet Res 1995, 56:801-805.
60. Knapp DW, Glickman NW, Widmer WR, et al. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother Pharmacol 2000, 46:221-226.
61. Mohammed SI, Bennett PF, Craig BA, et al. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res 2002, 62:356-358.
62. Schmidt BR, Glickman NW, DeNicola DB, et al. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 2001, 218:1783-1786.
63. Mutsaers AJ, Glickman NW, DeNicola DB, et al. Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs. J Am Vet Med Assoc 2002, 220:1813-1817.
64. Lees P, Taylor PM Pharmacodynamics and pharmacokinetics of flunixin in the cat. Br Vet J 1991, 147:298-305.
65. Parton K, Balmer TV, Boyle J, et al. The pharmacokinetics and effects of intravenously administered carprofen and salicylate on gastrointestinal mucosa and selected biochemical measurements in healthy cats. J Vet Pharmacol Ther 2000, 23:73-79.
66. Taylor PM, Delatour P, Landoni FM, et al. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. Res Vet Sci 1996, 60:144-151.
67. Taylor PM, Winnard JG, Jefferies R, et al. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study. Br Vet J 1994, 150:253-262.
68. Davies NM, Good RL, Roupe KA, et al. Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error? Not as easy as 1, 2, 3. J Pharm Pharm Sci 2004, 7:217-226.
69. Schwab JM, Schluesener HJ, Laufer S COX-3: just another COX or the solitary elusive target of paracetamol?. Lancet 2003, 361:981-982.
70. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002, 99:13926-13931.
71. Kukanich B, Lascelles BD, Aman A et al: Inhibition of cytochrome P4503A, P-glycoprotein and gastric acid secretion do not alter oral bioavailability of methadone in dogs, J Vet Pharm Ther (in press).
72. Kukanich B, Lascelles BD, Papich MG Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs. J Vet Pharmacol Ther 2005, 28:371-376.
73. Lascelles BD, Robertson SA Use of thermal threshold response to evaluate the antinociceptive effects of butorphanol in cats. Am J Vet Res 2004, 65:1085-1089.
74. Robertson SA, Taylor PM, Lascelles BD, et al. Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine. Vet Rec 2003, 153:462-465.
75. Lascelles BD, Robertson SA, Taylor PM, et al. Comparison of the pharmacokinetics and thermal antinociceptive pharmacodynamics of 20 mcg/kg buprenorphine administered sublingually or intravenously in cats. Vet Anaesth Analg 2003, 30:109. (abstract).
76. Woolf CJ, Thompson SWN The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implication for the treatment of post-injury pain hypersensitivity states. Pain 1991, 44:293-299.
77. Julius D, Basbaum AI Molecular mechanisms of nociception. Nature 2001, 413:203-210.
78. Graven-Nielsen T, Arendt-Nielsen L Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach. Curr Rheumatol Rep 2002, 4:313-321.
79. Fisher K, Coderre TJ, Hagen NA Targeting the N-methyl-D-aspartate receptor for chronic pain management: preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 2000, 20:358-373.
80. Wagner AE, Walton JA, Hellyer PW, et al. Use of low doses of ketamine administered by constant rate infusion as an adjunct for postoperative analgesia in dogs. J Am Vet Med Assoc 2002, 221:72-75.
81. Slingsby LS, Waterman-Pearson AE The post-operative analgesic effects of ketamine after canine ovariohysterectomy: a comparison between pre- or post-operative administration. Res Vet Sci 2000, 69:147-152.
82. Kukanich B, Papich MG Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs. J Vet Pharmacol Ther 2004, 27:337-341.
83. Pud D, Eisenberg E, Spitzer A, et al. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998, 75:349-354.
84. Eisenberg E, Pud D Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?. Pain 1998, 74:337-339.
85. Vernier VG, Harmon JB, Stump JM, et al. The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol 1969, 15:642-665.
86. Dayer P, Desmeules J, Collart L Pharmacology of tramadol. Drugs 1997, 2:18-24.
87. Oliva P, Aurilio C, Massimo F, et al. The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. Eur J Pharmacol 2002, 445:179-185.
88. Katz WA Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs 1996, 52(suppl 3):39-47.
89. Reig E Tramadol in musculoskeletal pain: a survey. Clin Rheumatol 2002, 21(suppl 1):S9-S11. (discussion, S11-S12).
90. Adler L, McDonald C, O'Brien C, et al. A comparison of once-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J Rheumatol 2002, 29:2196-2199.
91. Schnitzer TJ Non-NSAID pharmacologic treatment options for the management of chronic pain. Am J Med 1998, 105:45S-52S.
92. Kuraishi Y, Iida Y, Zhang HW, et al. Suppression by gabapentin of pain-related mechano-responses in mice given orthotopic tumor inoculation. Biol Pharm Bull 2003, 26:550-552.
93. Peters CM, Ghilardi JR, Keyser CP, et al. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain. Exp Neurol 2005, 193:85-100.
94. Buffington CAT Visceral pain in humans: lessons from animals. Curr Pain Headache Rep 2001, 5:44-51.
95. Buffington CAT, Chew DJ, Woodworth BE Feline interstitial cystitis. J Am Vet Med Assoc 1999, 215:682-687.
96. Luger NM, Honore P, Sabino MA, et al. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res 2001, 61:4038-4047.
97. Honore P, Luger NM, Sabino MA, et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 2000, 6:521-528.
98. Friedland J Local and systemic radiation for palliation of metastatic disease. Urol Clin North Am 1999, 26:391-402.
99. Janssens LA, Rogers PA, Schoen AM Acupuncture analgesia: a review. Vet Rec 1988, 122:355-358.
100. Wright M, McGrath CJ Physiologic and analgesic effects of acupuncture in the dog. J Am Vet Med Assoc 1981, 178:502-507.
101. Ulett GA, Han S, Han JS Electroacupuncture: mechanisms and clinical application. Biol Psychiatry 1998, 44:129-138.
102. Mantyh PW, Clohisy DR, Koltzenburg M, et al. Molecular mechanisms of cancer pain. Nat Rev Cancer 2002, 2:201-209.
103. Honore P, Schwei J, Rogers SD, et al. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog Brain Res 2000, 129:389-397.
104. Mantyh PW, Rogers SD, Honore P, et al. Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 1997, 278:275-279.
105. Nichols ML, Allen BJ, Rogers SD, et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999, 286:1558-1561. 106.
106. Carroll GL, Howe LB, Slater MR, et al. Evaluation of analgesia provided by postoperative administration of butorphanol to cats undergoing onychectomy. J Am Vet Med Assoc 1998, 213:246-250.
107. Lascelles BDX Clinical efficacy of meloxicam ("Metacam") in cats with locomotor disorders. J Small Anim Pract 2001, 42:587-593.
108. Franks JN, Boothe HW, Taylor L, et al. Evaluation of transdermal fentanyl patches for analgesia in cats undergoing onychectomy. J Am Vet Med Assoc 2000, 217:1013-1020.
109. Glerum LE, Egger CM, Allen SW, et al. Analgesic effect of the transdermal fentanyl patch during and after feline ovariohysterectomy. Vet Surg 2001, 30:351-358.
110. Fearon KCH, Barber MD, Moses AGW The cancer cachexia syndrome. Surg Oncol Clin North Am 2001, 10:109.
111. McKinlay AW Nutritional support in patients with advanced cancer: permission to fall out?. Proc Nutr Soc 2004, 63:431.
112. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980, 69:491.
113. Lees J Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology center. Eur J Cancer Care 1999, 8:133.
114. Strasser F, Bruera ED Update on anorexia and cachexia. Hematol Oncol Clin North Am 2002, 16:589.
115. Langer CJ, Hoffman JP, Ottery FD Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition 2001, 17:S1.
116. Gadducci A, Cosio S, Fanucchi A, et al. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management. Anticancer Res 2001, 21:2941.
117. Holder H Nursing management of nutrition in cancer and palliative care. Br J Nurs 2003, 12:667.
118. Tisdale MJ Biology of cachexia. J Natl Cancer Inst 1997, 89:1763.
119. Hill D, Hart K A practical approach to nutritional support for patients with advanced cancer. Int J Palliat Nurs 2001, 7:317.
120. Brennan MF Uncomplicated starvation versus cancer cachexia. Cancer Res 1977, 37:2359.
121. Brennan MF Total parenteral nutrition in the cancer patient. N Engl J Med 1981, 305:375.
122. Tisdale MJ Wasting in cancer. J Nutr 1999, 129:243S.
123. Sakurai Y, Klein S Metabolic alteration in patients with cancer: nutritional implications. Surg Today 1998, 28:247.
124. Roubenoff R Inflammatory and hormonal mediators of cachexia. J Nutr 1997, 127:1014S.
125. Tessitore L, Costelli P, Baccino FM Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer 1993, 67:15.
126. McCarthy DO Rethinking nutritional support for persons with cancer cachexia. Biol Res Nurs 2003, 5:3.
127. Gelin J, Moldawer LL, Lönnroth C, et al. Role of endogenous tumor necrosis factor α and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res 1991, 51:415.
128. Burt ME, Lowry SF, Gorschboth C, et al. Metabolic alterations in a noncachectic animal tumor system. Cancer 1981, 47:2138.
129. Price SA, Tisdale MJ Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid. Cancer Res 1998, 58:4827.
130. Vail DM, Ogilvie GK, Wheeler SL, et al. Alterations in carbohydrate metabolism in canine lymphoma. J Vet Intern Med 1990, 4:8.
131. Ogilvie GK, Vail DM, Wheeler SL, et al. Effects of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma. Cancer 1992, 69:233.
132. Ogilvie GK, Walter L, Salman MD, et al. Alterations in carbohydrate metabolism in dogs with nonhematopoietic malignancies. Am J Vet Res 1997, 58:277.
133. Ogilvie GK, Ford RB, Vail DM, et al. Alterations in lipoprotein profiles in dogs with lymphoma. J Vet Intern Med 1994, 8:62.
134. Mazzaferro EM, Hackett TB, Stein TP, et al. Metabolic alterations in dogs with osteosarcoma. Am J Vet Res 2001, 62:1234.
135. Ogilvie GK, Walters LM, Salman MD, et al. Resting energy expenditure in dogs with nonhematopoietic malignancies before and after excision of tumors. Am J Vet Res 1996, 57:1463.
136. Ogilvie GK, Walters LM, Fettman MJ, et al. Energy expenditure in dogs with lymphoma fed two specialized diets. Cancer 1993, 71:3146.
137. Daley BJ, Bistrian BR Nutritional assessment. Nutrition in critical care 1994, Mosby, St Louis. G.P. Zaloga (Ed.).
138. Michel KE, Sorenmo K, Shofer FS Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service. J Vet Intern Med 2004, 18:692.
139. Remillard RL, Armstrong PJ, Davenport DJ Assisted feeding in hospitalized patients: enteral and parenteral nutrition. Small animal clinical nutrition 2000, Mark Morris Institute, Topeka. ed 4. M.S. Hand, C.D. Thatcher, R.L. Remillard (Eds.).
140. Mauldin GE, Davidson JR Nutritional support of hospitalized cats and dogs. Textbook of small animal surgery 2003, WB Saunders, Philadelphia. ed 3. D. Slatter (Ed.).
141. Laflamme DP, Kealy RD, Schmidt DA Estimation of body fat by body condition score. J Vet Intern Med 1994, 8:154.
142. Mawby DI, Bartges JW, d'Avignon A, et al. Comparison of various methods for estimating body fat in dogs. J Am Anim Hosp Assoc 2004, 40:109.
143. Laflamme DP Development and validation of a body condition score system for dogs: a clinical tool. Canine Pract 1997, 22:10.
144. Laflamme DP Development and validation of a body condition score system for cats: a clinical tool. Feline Pract 1997, 25:13.
145. Lundholm K, Daneryd P, Bosaeus I, et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 2004, 100:1967.
146. Burkholder WJ, Toll PW Obesity. Small animal clinical nutrition 2000, Mark Morris Institute, Topeka. ed 4. M.S. Hand, C.D. Thatcher, R.L. Remillard (Eds.).
147. Fettman MJ Feline kaliopenic polymyopathy/nephropathy syndrome. Vet Clin North Am 1989, 19:415.
148. Fascetti AJ, Mauldin GE, Mauldin GN Correlation between serum creatine kinase activities and anorexia in cats. J Vet Intern Med 1997, 11:9.
149. Davenport DJ, Mostardi RA, Richardson DC, et al. Protein- deficient diet alters serum alkaline phosphatase, bile acids, protein and urea nitrogen in dogs. J Nutr 1994, 124:2677S.
150. Brown B, Mauldin GE, Armstrong J, et al. Metabolic and hormonal alterations in cats with hepatic lipidosis. J Vet Intern Med 2000, 14:20.
151. Center SA, Crawford MA, Guida L, et al. A retrospective study of 77 cats with severe hepatic lipidosis: 1975-1990. J Vet Intern Med 1993, 7:349.
152. Center SA, Baldwin BH, Dillingham S, et al. Diagnostic value of serum gamma-glutamyl transferase and alkaline phosphatase activities in hepatobiliary disease in the cat. J Am Vet Med Assoc 1986, 188:507.
153. Dixon FJ, Maurer PH, Deichmiller MP Half-lives of homologous serum albumins in several species. Proc Soc Exp Biol Med 1953, 83:287.
154. Zamboni G, Dufillot D, Antoniazzi F, et al. Growth hormone-binding proteins and insulin-like growth factor-binding proteins in protein-energy malnutrition, before and after nutritional rehabilitation. Pediatr Res 1996, 39:410.
155. Jacob V, Marchant PR, Wild G, et al. Nutritional profile of continuous ambulatory peritoneal dialysis patients. Nephron 1995, 71:16.
156. Laursen EM, Juul A, Lanng S, et al. Diminished concentrations of insulin-like growth factor I in cystic fibrosis. Arch Dis Child 1995, 72:494.
157. Anderson RS Water balance in the dog and cat. J Small Anim Pract 1982, 23:588.
158. Definition of terms. Nutritional energetics of domestic animals 1981, National Research Council Subcommittee on Biological Energy, National Research Council, Subcommittee on Biological EnergyNational Research Council, Subcommittee on Biological Energy, National Academy Press, Washington, DC.
159. Debraekeleer J, Gross KL, Zicker SC Normal dogs. Small animal clinical nutrition 2000, Mark Morris Institute, Topeka. ed 4. M.S. Hand, C.D. Thatcher, R.L. Remillard (Eds.).
160. Kirk CA, Debraekeleer J, Armstrong PJ Normal cats. Small animal clinical nutrition 2000, Mark Morris Institute, Topeka. ed 4. M.S. Hand, C.D. Thatcher, R.L. Remillard (Eds.).
161. Bartges JW Nutritional support. Complications in small animal surgery: diagnosis, management, prevention 1996, Williams & Wilkins, Baltimore. A.J. Lipowitz (Ed.).
162. Richardson RA, Davidson HIM Nutritional demands in acute and chronic illness. Proc Nutr Soc 2003, 62:777.
163. Vrees MD, Albina JE Metabolic response to illness and its mediators. Clinical nutrition: parenteral nutrition 2001, WB Saunders, Philadelphia. ed 3. J.L. Rombeau, R.H. Rolandelli (Eds.).
164. Meguid MM, Collier MD, Howard LJ Uncomplicated and stressed starvation. Surg Clin North Am 1981, 61:529.
165. Stein TP, Buzby GP Protein metabolism in surgical patients. Surg Clin North Am 1981, 61:519.
166. Picton SV Aspects of altered metabolism in children with cancer. Int J Cancer 1998, 11:62.
167. Lippert AC, Faulkner JE, Evans AT, et al. Total parenteral nutrition in clinically normal cats. J Am Vet Med Assoc 1989, 194:669.
168. Baker AL, Rosenberg IH Hepatic complications of total parenteral nutrition. Am J Med 1987, 82:489.
169. Sheldon GF, Petersen SR, Sanders R Hepatic dysfunction during hyperalimentation. Arch Surg 1978, 113:504.
170. Nordenstrom J, Jeevanandam M, Elwyn DB, et al. Increasing glucose intake during total parenteral nutrition increases norepinephrine excretion in trauma and sepsis. Clin Physiol 1981, 1:525.
171. Askanazi J, Weissman D, LaSala PA, et al. Effect of protein intake on ventilatory drive. Anesthesiology 1984, 60:106.
172. Lawler DF, Evans RH, Larson BT, et al. Influence of lifetime food restriction on causes, time, and predictors of death in dogs. J Am Vet Med Assoc 2005, 226:225.
173. Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Cancer 2000, 88:1916.
174. Kallfelz FA Evaluation and use of pet foods: general considerations in using pet food for adult maintenance. Vet Clin North Am 1989, 19:387.
175. Vaughn DM, Reinhart GA, Swaim SF, et al. Evaluation of effects of dietary n-6 to n-3 fatty acid ratios on leukotriene B synthesis in dog skin and neutrophils. Vet Dermatol 1994, 5:163.
176. Rosychuk RAW, Scott-Fieseler K, White SD et al: Nutritional management of canine atopy in 47 dogs: a retrospective study. Reinhart GA, Carey DP Recent advances in canine and feline nutrition, Proceedings of the 2000 Iams Nutrition Symposium, Wilmington, Delaware, 2000, Orange Frazer Press.
177. Scott DW, Miller WH, Reinhart GA, et al. Effect of an omega-3/omega-6 fatty acid-containing commercial lamb and rice diet on pruritus in atopic dogs: results of a single-blinded study. Can J Vet Res 1997, 61:145.
178. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320:265.
179. Meydani SN, Endres S, Woods MM, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991, 121:547.
180. Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998, 12:440.
181. Barber MD, McMillan DC, Preston T, et al. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) 2000, 98:389.
182. Barber MD, Fearson KCH, Tisdale MJ, et al. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001, 40:118.
183. Tisdale MJ, Dhesi JK Inhibition of weight loss by N-3 fatty acids in an experimental cachexia model. Cancer Res 1990, 50:5022.
184. Beck SA, Smith KL, Tisdale MJ Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res 1991, 51:6089.
185. Gogos CA, Ginopoulos P, Salsa B, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998, 82:395.
186. Spector AA, Burns CP Biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res 1987, 47:4529.
187. Bégin ME, Ells G, Das UN, et al. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986, 77:1053.
188. Kristensen SD, Schmidt EB, Dyerberg J Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. J Intern Med Suppl 1989, 731:141.
189. Boudreaux MK, Reinhart GA, Vaughn DM, et al. The effects of varying dietary n-6 to n-3 fatty acid ratios on platelet reactivity, coagulation screening assays, and antithrombin III activity in dogs. J Am Anim Hosp Assoc 1997, 33:235.
190. McNeil EA, Ogilvie GK, Mallinckrodt C, et al. Platelet function in dogs treated for lymphoma and hemangiosarcoma and supplemented with dietary n-3 fatty acids. J Vet Intern Med 1999, 13:574.
191. Saker K, Eddy A, Thatcher C, et al. Manipulation of dietary (n-6) and (n-3) fatty acids alters platelet function in cats. J Nutr 1998, 128:2645S.
192. Wander RC, Hall JA, Gradin JL, et al. The ratio of dietary (n-6) to (n-3) fatty acids influences immune system function, eicosanoid metabolism, lipid peroxidation and vitamin E status in aged dogs. J Nutr 1997, 127:1198.
193. Mooney MA, Vaughn DM, Reinhart GA, et al. Evaluation of the effects of omega-3 fatty acid-containing diets on the inflammatory stage of wound healing in dogs. Am J Vet Res 1998, 59:859.
194. Smith RJ Glutamine metabolism and its physiologic importance. J Parenter Enteral Nutr 1990, 14:40S.
195. Smith RJ, Wilmore DW Glutamine nutrition and requirements. J Parenter Enteral Nutr 1990, 14:94S.
196. Kapadia CR, Colpoys MF, Jiang ZM, et al. Maintenance of skeletal muscle intracellular glutamine during standard surgical trauma. J Parenter Enteral Nutr 1985, 9:583.
197. Millward DJ, Jepson MM, Omer A, et al. Muscle glutamine and protein turnover in vivo in malnutrition and in endotoxemia. Metabolism 1989, 8(suppl):6.
198. Rennie MJ, MacLennan PA, Hundal HS, et al. Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover. Metabolism 1989, 8(suppl):47.
199. Vinnars E, Hammarqvist F, von der Decken A, et al. Role of glutamine and its analogs in posttraumatic muscle protein and amino acid metabolism. J Parenter Enteral Nutr 1990, 14:125S.
200. MacLennan PA, Smith K, Weryk B, et al. Inhibition of protein breakdown by glutamine in perfused rat skeletal muscle. FEBS Let 1988, 237:133.
201. Wu G, Thompson JR The effect of glutamine on protein turnover in chick skeletal muscle in vitro. Biochem J 1990, 265:593.
202. Hammarqvist F, Wernerman J, von der Decken A, et al. Alanyl-glutamine counteracts the depletion of free glutamine and the postoperative decline in protein synthesis in skeletal muscle. Ann Surg 1990, 212:637.
203. Stehle P, Zander J, Mertes N, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1989, 1:213.
204. Yoshida S, Kaibara A, Ishibashi N, et al. Glutamine supplementation in cancer patients. Nutrition 2001, 17:766.
205. Remillard RL, Guerino F, Dudgeon DL, et al. Intravenous glutamine or limited enteral feeding in piglets: amelioration of small intestinal disuse atrophy. J Nutr 1998, 128:2723S.
206. Souba WW, Klimberg VS, Plumley DA, et al. The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res 1990, 48:383.
207. Souba WW, Austgen TR Interorgan glutamine flow following surgery and infection. J Parenter Enteral Nutr 1990, 14:90S.
208. Souba WW, Herskowitz K, Salloum RM, et al. Gut glutamine metabolism. J Parenter Enteral Nutr 1990, 14:45S.
209. Brown MG, Campbell GR, Rowlands BJ Glutamine-enhanced enteral diet improves nitrogen balance without increasing portal ammonia. Br J Surg 1991, 78:1305.
210. Gouttebel MC, Astre C, Briand D, et al. Influence of N-acetylglutamine or glutamine infusion on plasma amino acid concentrations during the early phase of small-bowel adaptation in the dog. J Parenter Enteral Nutr 1992, 16:117.
211. Gouttebel MC, Astre C, Girardot PM, et al. Clinical, biological, and histological follow-up during intestinal adaptation after small-bowel resection in the dog. Eur Surg Res 1991, 23:333.
212. Ito A, Higashiguchi T Effects of glutamine administration on liver regeneration following hepatectomy. Nutrition 1999, 15:23.
213. Khanna C, Klausner JS, Walter P et al: A randomized clinical trial of glutamine versus placebo in the prevention of radiation-induced mucositis in dogs, Proceedings of the Fifteenth Annual Conference of the Veterinary Cancer Society, Tucson, October 1995.
214. Nitenberg G, Raynard B Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 2000, 34:137.
215. Barbul A, Hurson M Arginine. Nutrition in critical care 1994, Mosby, St Louis. G.P. Zaloga (Ed.).
216. Moskovitz DN, Kim Y-I Does perioperative immunonutrition reduce postoperative complications in patients with gastrointestinal cancer undergoing operations?. Nutr Rev 2004, 62:443.
217. Barbul A, Fishel RS, Shimazu S, et al. Intravenous hyperalimentation with high arginine levels improves wound healing and immune function. J Surg Res 1985, 38:328.
218. Chyun J, Griminger P Improvement of nitrogen retention by arginine and glycine supplementation and its relation to collagen synthesis in traumatized mature and aged rats. J Nutr 1984, 114:1697.
219. Seifter E, Rettura G, Barbul A, et al. Arginine: an essential amino acid for injured rats. Surgery 1978, 84:224.
220. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1998, 208:512.
221. Brittenden J, Heys SD, Ross J, et al. Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation. Eur J Surg Oncol 1994, 20:467.
222. Bruce DM, Heys SD, Segar A, et al. Enhancement of tumor infiltrating lymphocytes in human tumors by dietary supplementation with L-arginine. Br J Surg 1995, 82:703.
223. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992, 112:56.
224. Brittenden J, Heys SD, Eremin O L-arginine and malignant disease: a potential therapeutic role?. Eur J Surg Oncol 1994, 20:189.
225. Caparros T, Lopez J, Grau T Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet: the effect in nosocomial infections and outcome. J Parenter Enteral Nutr 2001, 25:299.
226. Johnson IT Micronutrients and cancer. Proc Nutr Soc 2004, 63:587.
227. Rao DN, Ganesh B, Rao RS, et al. Risk assessment of tobacco, alcohol, and diet in oral cancer: a case-control study. Int J Cancer 1994, 58:469.
228. Llewellyn CD, Linklater K, Bell J, et al. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004, 40:304.
229. Llewellyn CD, Linklater K, Bell J, et al. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the southeast of England from 1990 to 1997. Oral Oncol 2003, 39:106.
230. Zheng TZ, Boyle P, Hu HF, et al. Tobacco smoking, alcohol consumption, and risk of oral cancer: a case-control study in Beijing, People's Republic of China. Cancer Causes Control 1990, 1:173.
231. Mason JB, Levesque T Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology 1996, 10:1727.
232. 12 and folate deficiencies in carcinogenesis. Adv Exp Med Biol 1986, 206:313.
233. Almadori G, Bussu F, Galli J, et al. Serum folate and homocysteine levels in head and neck squamous cell carcinoma. Cancer 2002, 94:1006.
234. Piyathilake CJ, Johanning GL Cellular vitamins, DNA methylation and cancer risk. J Nutr 2002, 132:2340S.
235. Butterworth CE, Hatch KD, Gore H, et al. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 1982, 35:73.
236. 12: report of a preliminary randomized, double-blind intervention trial. J Am Med Assoc 1988, 259:1525.
237. Xiao SD, Meng XJ, Shi Y, et al. Interventional study of high dose folic acid in gastric carcinogenesis in beagles. Gut 2002, 50:61.
238. Duthie SJ, Narayanan S, Brand GM, et al. Impact of folate deficiency on DNA stability. J Nutr 2002, 132:2444S.
239. Jhaveri MS, Wagner C, Trepel JB Impact of extracellular folate levels on global gene expression. Mol Pharmacol 2001, 60:1288.
240. Kumaraguruparan R, Balachandran C, Manohar BM, et al. Altered oxidant-antioxidant profile in canine mammary tumours. Vet Res Commun 2005, 29:287.
241. Waters DJ, Shen S, Cooley DM, et al. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 2003, 95:237.
242. Steinmetz KA, Potter JD Vegetables, fruit and cancer. I. Epidemiology. Cancer Causes Control 1991, 2:325.
243. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996, 334:1145.
244. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. J Am Med Assoc 2005, 293:1338.
245. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996, 334:1150.
246. Bairati I, Meyer F, Gélinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005, 97:481.
247. Mercadante S Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 1998, 6:85.
248. Deutsch J, Kolhouse JF Assessment of gastrointestinal function and response to megestrol acetate in subjects with gastrointestinal cancers and weight loss. Support Care Cancer 2004, 12:503.
249. Nelson KA, Walsh D, Hussein M A phase II study of low-dose megestrol acetate using twice-daily dosing for anorexia in nonhormonally dependent cancer. Am J Hosp Palliat Care 2002, 19:206.
250. McQuellon RP, Moose DB, Russell GB, et al. Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy. Int J Radiat Oncol Biol Phys 2002, 52:1180.
251. Middleton DJ, Watson ADJ Glucocorticoid intolerance in cats given short-term therapies of prednisolone and megestrol acetate. Am J Vet Res 1985, 46:2623.
252. Misdorp W Progestagens and mammary tumors in dogs and cats. Acta Endocrinol (Copenh) 1991, 125:27.
253. Tomlinson MJ, Barteaux L, Ferns LE, et al. Feline mammary carcinoma: a retrospective evaluation of 17 cases. Can Vet J 1984, 25:435.
254. Baron M Appetite stimulants: the unsolved truth. Health Care Food Nutr Focus 2000, 16:5.
255. Forchielli ML, Paolucci G, Lo CW Total parenteral nutrition and home parenteral nutrition: an effective combination to sustain malnourished children with cancer. Nutr Rev 1999, 57:15.
256. Cohen J, Lefor AT Nutrition support and cancer. Nutrition 2001, 17:698.
257. Alverdy JC, Chi HS, Sheldon GF The effect of parenteral nutrition on gastrointestinal immunity: the importance of enteral stimulation. Ann Surg 1985, 202:681.
258. Bristol JB, Williamson RCN Nutrition, operations, and intestinal adaptation. J Parenter Enteral Nutr 1988, 12:299.
259. O'Dwyer ST, Smith RJ, Hwang TL, et al. Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition. J Parenter Enteral Nutr 1989, 13:579.
260. Weisbrodt NW, Copeland EM, Thor PJ, et al. The myoelectric activity of the small intestine of the dog during total parenteral nutrition. Proc Soc Exp Biol Med 1976, 153:121.
261. Feldman EJ, Dowling RH, McNaughton J, et al. Effects of oral versus intravenous nutrition on intestinal adaptation after small bowel resection in the dog. Gastroenterology 1976, 70:712.
262. Torosian MH, Donoway RB Total parenteral nutrition and tumor metastasis. Surgery 1991, 109:597.
263. Miller CC, Barges JW Refeeding syndrome. Kirk's current veterinary therapy XIII 2000, WB Saunders, Philadelphia. J.D. Bonagura (Ed.).
264. Justin RB, Hohenhaus AE Hypophosphatemia associated with enteral alimentation in cats. J Vet Intern Med 1995, 9:228.
265. Hopkins K Food for life, love and hope: an exemplar of the philosophy of palliative care in action. Proc Nutr Soc 2004, 63:427.
266. Angus F, Burakoff R The percutaneous endoscopic gastrostomy tube: medical and ethical issues in placement. Am J Gastroenterol 2003, 98:272.
267. Niv Y, Abuksis G Indications for percutaneous endoscopic gastrostomy insertion: ethical aspects. Dig Dis 2002, 20:253.
268. McKinlay AW Nutritional support in patients with advanced cancer: permission to fall out?. Proc Nutr Soc 2004, 63:431.
269. Miller CC, Bartges JW Parenteral nutrition products. Kirk's current veterinary therapy XIII 2000, WB Saunders, Philadelphia. J.D. Bonagura (Ed.).
270. Chandler ML, Guilford WG, Payne-James J Use of peripheral parenteral nutritional support in dogs and cats. J Am Vet Med Assoc 2000, 216:669.
271. Freeman LM, Labato MA, Rush JE, et al. Nutritional support in pancreatitis: a retrospective study. Vet Emerg Crit Care 1995, 5:32.
272. Lippert AC, Fulton RB, Parr AM A retrospective study of the use of total parenteral nutrition in dogs and cats. J Vet Intern Med 1993, 7:52.
273. Reuter JD, Marks SL, Rogers QR, et al. Use of total parenteral nutrition in dogs: 209 cases (1988-1995). Vet Emerg Crit Care 1998, 8:201.
274. Sonnenschein EG, Glickman LT, Goldschmidt MH, et al. Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. Am J Epidemiol 1991, 133:694.
275. Alenza DP, Rutteman GR, Pena L, et al. Relation between habitual diet and canine mammary tumors in a case-control study. J Vet Intern Med 1998, 12:132.
276. Buffington CAT, Holloway D, Abood S Cancer. Manual of veterinary dietetics 2004, Elsevier, St Louis.
277. Crow SE Psychological aspects of veterinary clinical oncology. Semin Vet Med Surg (Small Anim) 1986, 1:84-90.
278. McMillan FD Comfort as the primary goal in veterinary medical practice. J Am Vet Med Assoc 1998, 212:19.
279. Brecht M Nursing's role in assuring access to care. Nurs Outlook 1990, 38:6.
280. Moseley J Symposium on compassionate care and the dying experience: alterations in comfort. Nurs Clin North Am 1985, 20:427-438.
281. Skeat WW An etymological dictionary of the English language 1980, Clarendon Press, Oxford, England.
282. Lagoni L, Butler C, Hetts S The human-animal bond and grief 1994, WB Saunders, Philadelphia.
283. Brown JP, Silverman JD The current and future market for veterinarians and veterinary medical services in the United States. J Am Vet Med Assoc 1999, 215:161-183.
284. American Animal Hospital Association The 1995 AAHA report: a study of the companion animal veterinary services market 1995, The Association, Lakewood, Colorado.
285. Friedmann E The role of pets in enhancing human well-being: physiological effects. The Waltham book of human-animal interaction: benefits and responsibilities of pet ownership 1995, Pergamon, Oxford. I. Robinson (Ed.).
286. Melson GF, Sparks C, Peet S: Children's ideas about pets and their care, Paper presented at the annual meeting of the Delta Society, Parsippany, New Jersey, 1989.
287. Baun MM, McCabe B The role animals play in enhancing quality of life for the elderly. The handbook on animal assisted therapy 2000, Academic Press, San Diego. A. Fine (Ed.).
288. Odendaal J Pets and our mental health: the why, the what, and the how 2002, Vantage Press, New York.
289. Gage G, Holcomb R Couples' perceptions of the stressfulness of the death of the family pet. Fam Relat 1991, 40:103-105.
290. Rando TA Grief, dying and death: clinical interventions for caregivers 1984, Research Press, Champaign, Illinois.
291. Frey WH, Lanseth M Crying: the mystery of tears 1985, Winston Press, Minneapolis.
292. Kübler-Ross E On death and dying 1969, Collier Books/MacMillian, New York.
293. Parkes M Bereavement: studies of grief in adult life 1972, International University Press, New York.
294. Lagoni L, Morehead D, Brannan J, et al. Guidelines for bond-centered practice 2001, Argus Institute at Colorado State University, Fort Collins, Colorado.
295. Lagoni L The practical guide to grief 1996, AAHA Press, Denver.
296. Gershon D, Straub G Empowerment: the art of creating your life as you want it 1989, Dell, New York.
297. Maddison D, Walker WL Factors affecting the outcome of conjugal bereavement. Br J Psychiat 1967, 113:1057-1067.
298. Loss An interview with University of Chicago's Froma Walsh. Psychol Today 1992, 25:64-94.
299. Cook AS, Dworkin DS Helping the bereaved: therapeutic interventions for children, adolescents, and adults 1992, Basic Books, New York.
300. Vachon MLS Staff stress in the case of the terminally ill. Qual Rev Bull 1979, 5:13-17.
301. Lazare A Outpatient psychiatry: diagnosis and treatment 1979, Williams & Wilkins, Baltimore.
302. Cook AS, Oltjenbruns K Dying and grieving: lifespan and family perspectives 1989, Holt, Rhinehart, & Winston, New York.
303. Peteet JR, Medeiros C, Walsh-Burke K, et al. Job stress and satisfaction among the staff members at a cancer center. Cancer 1989, 64:975-982.
304. Hart LA, Hart BL Grief and stress from so many animal deaths. Comp Anim Pract 1987, 1:20-21.
305. Crowell-Davis SL, Crowe DS, Levine DL Death and euthanasia: attitudes of students and faculty at a veterinary teaching hospital. Euthanasia of the companion animal: the impact on pet owners, veterinarians, and society 1988, The Charles Press, Philadelphia, . W.J. Kay, S.P. Cohen, C.E. Fudin (Eds.).
306. Hart LA, Hart L, Mader B Humane euthanasia and companion animal death: caring for the animal, the client, and the veterinarian (special commentary). J Am Vet Med Assoc 1990, 197:1292-1299.
307. Abelhoff MD Burnout in oncology: physician heal thyself. J Clin Oncol 1991, 9:1721-1722.
308. Slaikeu KA Crisis intervention: a handbook for practice and research 1984, Allyn & Bacon, Newton, Massachusetts.
309. McConnell D, Butow PN, Tattersall MHN Audiotapes and letters to patients: the practice and views of oncologists, surgeons and general practitioners. Br J Cancer 1999, 79:1782-1788.
310. Luks A The healing power of doing good 1993, Ballantine Books, New York.
311. Choen SP Fudin CE, editors: Problems in Veterinary Medicine: Animal Illness and Human Emotion, Vol. 3, No.1, March 1991. Press, India, available from Blackwell Publishing.
312. Downing R Pets living with cancer: a pet owner's resource, Lakewood, Colo. 2000, AAHA Press.
313. Hunt LE Angel paw prints: an anthology of pet memorials 1998, Darrowby Press, Pasadena, Calif.
314. Hunt LE Angel whiskers:reflections on loving and losing a feline companion 2001, Hyperion Press, New York.
315. Argus Institute for Families and Veterinary Medicine: Grief support and education, Available at , James L. Voss Veterinary Teaching Hospital, Colorado State University, Fort Collins, Colorado, 80523. http://www.argusinstitute.colostate.edu.
316. Canfield J, Hansen MV, Becker M, et al. Chicken soup for the pet lover's soul 1998, Deerfield Beach, Fla., Health Communications.
317. Carmack B Grieving the death of a pet 2003, Augsburg Fortress, Minneapolis.
318. ClayPaws, the original paw print kit, and ComfortMats, Fort Collins, Colorado, Available at . http://www.claypaws.com.
319. Downing R Pets living with cancer: a pet owner's resource 2000, AAHA Press, Denver.
320. Lagoni L The practical guide to client grief: support techniques for 15 common situations 1997, AAHA Press, Denver.
321. Lagoni L, Butler C, Hetts S The human-animal bond and grief 1994, WB Saunders, Philadelphia.
322. Lagoni L, Morehead D, Brannan J, et al. Guidelines for bond-centered practice, Argus Institute for Families and Veterinary Medicine 2001, Colorado State University, Fort Collins.
323. Morehead D A special place for Charlee 1996, Partners in Publishing, Broomfield, Colo.
324. Odendaal J Pets and our mental health: the why, the what, and the how 2002, Vantage Press, New York.
325. Rylant C Cat heaven 1997, Blue Sky Press, New York.
326. Rylant C Dog heaven 1995, Blue Sky Press, New York.
327. Sotile WM, Sotile MO The resilient physician: effective emotional management for doctors and their medical organizations 2002, AMA Press, Chicago.